Glen Harbor Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Glen Harbor Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$2.84M	Sell	10,234 -136	-1%	-$40.2K	0.06%	270
2019 Q2	$3.25M	Sell	10,370 -8,568	-45%	-$2.85M	0.07%	252
2019 Q1	$7.78M	Buy	18,938 +12,750	+206%	+$5.25M	0.17%	125
2018 Q4	$2.31M	Buy	6,188 +1,666	+37%	+$610K	0.06%	291
2018 Q3	$1.83M	Buy	4,522 +1,020	+29%	+$388K	0.04%	351
2018 Q2	$1.21M	Buy	3,502 +68	+2%	+$21.3K	0.03%	393
2018 Q1	$1.18M	Sell	3,434 -578	-14%	-$201K	0.03%	383
2017 Q4	$1.51M	Buy	4,012 +1,870	+87%	+$757K	0.03%	353
2017 Q3	$958K	Sell	2,142 -102	-5%	-$48.5K	0.02%	419
2017 Q2	$1.1M	Sell	2,244 -238	-10%	-$104K	0.03%	404
2017 Q1	$962K	Sell	2,482 -34	-1%	-$12.6K	0.02%	412
2016 Q4	$923K	Buy	+2,516	New	+$957K	0.03%	385

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Glen Harbor Capital Management's REGN Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2019, selling an estimated $40.2K and leaving 10,234 shares worth $2.84M. The position accounts for 0.06% of the portfolio, ranked #270.

Glen Harbor Capital Management first reported a position in REGN in Q4 2016 and has held it in 12 quarters since. The position peaked at $7.78M in Q1 2019. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

Glen Harbor Capital Management held 10,234 shares of Regeneron Pharmaceuticals worth $2.84M as of Q3 2019.
Glen Harbor Capital Management sold 136 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $40.2K.
Regeneron Pharmaceuticals made up 0.06% of Glen Harbor Capital Management's portfolio in Q3 2019, its #270 holding.
Glen Harbor Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Regeneron Pharmaceuticals position peaked at $7.78M in Q1 2019.
633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.